Vitamin D3 triggers antitumor activity through targeting hedgehog signaling in human renal cell carcinoma. (Q53154285)

11 May 2018

title

Vitamin D3 triggers antitumor activity through targeting hedgehog signaling in human renal cell carcinoma. (English)

1 reference

11 May 2018

1 reference

Valérian Dormoy

1

0 references

Thierry Massfelder

9

Thierry Massfelder

1 reference

11 May 2018

Mariette Barthelmebs

5

Mariette Barthelmebs

1 reference

11 May 2018

Catherine Coquard

4

Catherine Coquard

1 reference

11 May 2018

Véronique Lindner

3

Véronique Lindner

1 reference

11 May 2018

author name string

Claire Béraud

2

1 reference

11 May 2018

David Brasse

6

1 reference

11 May 2018

Didier Jacqmin

7

1 reference

11 May 2018

Hervé Lang

8

1 reference

11 May 2018

language of work or name

English

0 references

publication date

28 July 2012

1 reference

11 May 2018

published in

Carcinogenesis

1 reference

11 May 2018

volume

33

1 reference

11 May 2018

issue

11

1 reference

11 May 2018

page(s)

2084-2093

1 reference

11 May 2018

The changing pattern of kidney cancer incidence and mortality in Europe

cites work

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS255

21 January 2018

Cancer statistics, 2009

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS255

The epidemiology of renal cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS255

Everolimus (RAD001) in the treatment of advanced renal cell carcinoma: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS255

Parathyroid hormone-related protein in human renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS255

The role of VHL in clear-cell renal cell carcinoma and its relation to targeted therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS255

Von Hippel-Lindau disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS255

The phosphoinositide 3-kinase/Akt pathway: a new target in human renal cell carcinoma therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS255

Inhibition of MAPK kinase signaling pathways suppressed renal cell carcinoma growth and angiogenesis in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS255

Targeting the nuclear factor-kappaB rescue pathway has promising future in human renal cell carcinoma therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS255

Suppression of renal cell carcinoma growth by inhibition of Notch signaling in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS255

Expression and clinical significance of Notch receptors in human renal cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS255

In vivo validation of PAX2 as a target for renal cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS255

PAX2 inactivation enhances cisplatin-induced apoptosis in renal carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS255

The sonic hedgehog signaling pathway is reactivated in human renal cell carcinoma and plays orchestral role in tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS255

LIM-class homeobox gene Lim1, a novel oncogene in human renal cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS255

Expression of the vitamin D receptor, 25-hydroxylases, 1alpha-hydroxylase and 24-hydroxylase in the human kidney and renal clear cell cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS255

Vitamin d pathway genes, diet, and risk of renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS255

Assessing the efficacy of the hedgehog pathway inhibitor vitamin D3 in a murine xenograft model for pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS255

The role of Vitamin D3 metabolism in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS255

Health effects of vitamin D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS255

Quantification of mRNA for the vitamin D metabolizing enzymes CYP27B1 and CYP24 and vitamin D receptor in kidney using real-time reverse transcriptase- polymerase chain reaction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS255

Mechanisms of the anti-cancer and anti-inflammatory actions of vitamin D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS255

Vitamin D and kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS255

Antitumoral effects of calcitriol in basal cell carcinomas involve inhibition of hedgehog signaling and induction of vitamin D receptor signaling and differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS255

Repression of smoothened by patched-dependent (pro-)vitamin D3 secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS255

Vitamin D3 inhibits hedgehog signaling and proliferation in murine Basal cell carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS255

Parathyroid hormone-related protein is an essential growth factor for human clear cell renal carcinoma and a target for the von Hippel-Lindau tumor suppressor gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS255

Effect of prior treatment with resveratrol on density and structure of rat long bones under tail-suspension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS255

Benefit-risk assessment of vitamin D supplementation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS255

Estimated benefit of increased vitamin D status in reducing the economic burden of disease in western Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS255

Vitamin D in combination cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS255

Vitamin D: considerations in the continued development as an agent for cancer prevention and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS255

Prevention of renal cell carcinoma by active vitamin D3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS255

Inhibitory effect of 1 alpha,25-dihydroxyvitamin D3 on the growth of the renal carcinoma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS255

A vitamin D receptor-alkylating derivative of 1α,25-dihydroxyvitamin D3 inhibits growth of human kidney cancer cells and suppresses tumor growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS255

Overexpression of hedgehog signaling is associated with epidermal tumor formation in vitamin D receptor-null mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS255

Treatment of K562 cells with 1,25-dihydroxyvitamin D3 induces distinct alterations in the expression of apoptosis-related genes BCL2, BAX, BCLXL, and p21.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS255

Angiogenesis and angiogenic inhibitors in renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS255

Anti-angiogenic therapy in renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS255

Signaling pathways in renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS255

New vitamin D analogs and changing therapeutic paradigms

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS255

21 January 2018

Identifiers

DOI

10.1093/CARCIN/BGS255

1 reference

11 May 2018

PubMed ID

22843547

1 reference

11 May 2018